4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001415889-25-022225
Director acquired 26,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kaye Edward M. MD Director | 2025-08-14 | Option exercise | +26,250 | 165,596 | D | ||
| Derivatives | |||||||
| Kaye Edward M. MD Director | 2025-08-14 | Grant or award · Performance Stock Units | +52,500 | 52,500 | D | ||
| Kaye Edward M. MD Director | 2025-08-14 | Option exercise · Performance Stock Units | −26,250 | 26,250 | D | ||
Loading xslF345X05/form4-08192025_120819.xml…